Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.5.3.6 extracted from

  • Feun, L.; Savaraj, N.
    Pegylated arginine deiminase: a novel anticancer enzyme agent (2006), Expert Opin. Investig. Drugs, 15, 815-822.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
pharmacology ADI has anti-cancer activity by causing depletion of L-arginine, fusion of ADI to 20 kDa PEG improves its pharmaceutical efficiency by increasing the half-life of the enzyme in serum, clinical studies, overview Mycoplasma hominis

Cloned(Commentary)

Cloned (Comment) Organism
expression in Escherichia coli Mycoplasma hominis

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
46000
-
x * 46000, about, SDS-PAGE Mycoplasma hominis

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
L-arginine + H2O Mycoplasma hominis
-
L-citrulline + NH3
-
?
additional information Mycoplasma hominis ADI has anti-cancer activity by causing depletion of L-arginine by reducing the circulating amount, fusion of ADI to 20 kDa PEG improves its pharmaceutical efficiency, overview ?
-
?

Organism

Organism UniProt Comment Textmining
Mycoplasma hominis
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
L-arginine + H2O
-
Mycoplasma hominis L-citrulline + NH3
-
?
additional information ADI has anti-cancer activity by causing depletion of L-arginine by reducing the circulating amount, fusion of ADI to 20 kDa PEG improves its pharmaceutical efficiency, overview Mycoplasma hominis ?
-
?

Subunits

Subunits Comment Organism
? x * 46000, about, SDS-PAGE Mycoplasma hominis

Synonyms

Synonyms Comment Organism
ADI
-
Mycoplasma hominis